Novel polymeric micelles based on the amphiphilic diblock copolymer poly(N-vinyl-2-pyrrolidone)-block-poly(D,L-lactide)

被引:113
作者
Benahmed, A [1 ]
Ranger, M [1 ]
Leroux, JC [1 ]
机构
[1] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
poly(N-vinyl-2-pyrrolidone) (PVP); poly(D; L-lactide) (PDLLA); colloids; diblock copolymer; polymeric micelles; drug carrier; indomethacin;
D O I
10.1023/A:1011054930439
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The purpose of this work was to synthesize a new amphiphilic diblock copolymer of poly(N-vinyl-2-pyrrolidone and poly(D,L-lactide) (PVP-b-PDLLA) capable of self-assembling into polymeric micelles with multiple binding sites and high entrapment efficiency. Methods. The copolymer was synthesized by ring-opening polymerization of D,L-lactide initiated by potassium PVP hydroxylate. It was characterized by gel permeation chromatography,H-1- and C-13-NMR spectroscopy. The ability of the copolymer to self-assemble was demonstrated by dynamic and static light scattering, spectrofluorimetry and H-1-NMR. The hydrophobic model drug indomethacin was incorporated into the polymeric micelles by a dialysis procedure. Results. A series of amphiphilic diblock copolymers based on PVP-b-PDLLA were successfully synthesized. The critical association concentrations in water were low, always below 15 mg/L. Micellar size was generally bimodal with a predominant population between 40 and 100 nm. PVP-b-PDLLA micelles were successfully loaded with the poorly water-soluble drug indomethacin and demonstrated an entrapment efficiency higher than that observed with control poly(ethylene glycol)-b-PDLLA micelles. It was hypothesized that specific interactions with the hydrophilic outer shell could contribute to the increase in drug loading. Conclusion. PVP-b-PDLLA micelles appear to exhibit multiple binding sites and thus represent a promising strategy for the delivery of a variety of drugs.
引用
收藏
页码:323 / 328
页数:6
相关论文
共 30 条
[1]   Polycaprolactone-b-poly(ethylene oxide) block copolymer micelles as a novel drug delivery vehicle for neurotrophic agents FK506 and L-685,818 [J].
Allen, C ;
Yu, YS ;
Maysinger, D ;
Eisenberg, A .
BIOCONJUGATE CHEMISTRY, 1998, 9 (05) :564-572
[2]   Nano-engineering block copolymer aggregates for drug delivery [J].
Allen, C ;
Maysinger, D ;
Eisenberg, A .
COLLOIDS AND SURFACES B-BIOINTERFACES, 1999, 16 (1-4) :3-27
[3]   CRITICAL MICELLIZATION PHENOMENA IN BLOCK POLYELECTROLYTE SOLUTIONS [J].
ASTAFIEVA, I ;
ZHONG, XF ;
EISENBERG, A .
MACROMOLECULES, 1993, 26 (26) :7339-7352
[4]  
BETTINETTI G P, 1988, Farmaco Edizione Pratica, V43, P331
[5]   Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles:: Influence on physical stability and in vitro cell uptake [J].
De Jaeghere, F ;
Allémann, E ;
Leroux, JC ;
Stevels, W ;
Feijen, J ;
Doelker, E ;
Gurny, R .
PHARMACEUTICAL RESEARCH, 1999, 16 (06) :859-866
[6]  
DEIIARDUYA MCT, 1998, DRUG DEV IND PHARM, V24, P295
[7]   CRYOPROTECTIVE COMPOUNDS - REVIEW AND DISCUSSION OF STRUCTURE AND FUNCTION [J].
DOEBBLER, GF .
CRYOBIOLOGY, 1966, 3 (01) :2-+
[8]   Graft copolymers for biomedical applications prepared by free radical polymerization of poly(L-lactide) macromonomers with vinyl and acrylic monomers [J].
Eguiburu, JL ;
FernandezBerridi, MJ ;
Roman, JS .
POLYMER, 1996, 37 (16) :3615-3622
[9]   THE STABILIZATION OF A HUMAN-IGM MONOCLONAL-ANTIBODY WITH POLY(VINYLPYRROLIDONE) [J].
GOMBOTZ, WR ;
PANKEY, SC ;
PHAN, D ;
DRAGER, R ;
DONALDSON, K ;
ANTONSEN, KP ;
HOFFMAN, AS ;
RAFF, HV .
PHARMACEUTICAL RESEARCH, 1994, 11 (05) :624-632
[10]   Polylactide-poly(ethylene glycol) copolymers as drug delivery systems .1. Characterization of water dispersible micelle-forming systems [J].
Hagan, SA ;
Coombes, AGA ;
Garnett, MC ;
Dunn, SE ;
Davis, MC ;
Illum, L ;
Davis, SS ;
Harding, SE ;
Purkiss, S ;
Gellert, PR .
LANGMUIR, 1996, 12 (09) :2153-2161